FRESENIUS/ DE0005785604 /

8/9/2022 10:36:33 AM	Chg. +0.180	Volume	Bid5:55:00 PM	Ask5:55:00 PM	Market Capitalization	Dividend Y.	P/E Ratio
24.630EUR	+0.74%	1 Turnover: 24.630	-Bid Size: -	-Ask Size: -	13.76 bill.EUR	3.74%	7.56

GlobeNewswire 6/11/2021 UPDATE -- Humacyte Expands Strategic Global Partnership with Fresenius Medical Care

GlobeNewswire 6/11/2021 Humacyte Expands Strategic Global Partnership with Fresenius Medical Care

GlobeNewswire 2/4/2021 Cove Capital Acquires Fresenius Medical Care Dialysis Facility in New Orleans

GlobeNewswire 11/11/2019 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fresenius Medica...

GlobeNewswire 11/7/2019 eGenesis Announces $100 Million Series B Financing

GlobeNewswire 11/4/2019 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fresenius Medica...

GlobeNewswire 10/29/2019 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Fresenius Medica...

GlobeNewswire 10/23/2019 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fresenius Medic...

GlobeNewswire 2/20/2019 Akorn Comments on Fresenius’ Proposed Amended Claims

GlobeNewswire 10/18/2018 Akorn Appeals Fresenius Kabi Ruling

GlobeNewswire 7/16/2018 OPKO Partner Vifor Fresenius Receives Marketing Approval for RAYALDEE in Canada

GlobeNewswire 2/21/2018 Global Kidney Dialysis Equipment and Supplies Markets 2016-2024: Fresenius and Baxter Dominate the M...

TeleTrader 8/7/2017 Fresenius Medical buys NxStage for $2 billion

GlobeNewswire 7/19/2017 Akorn Shareholders Vote to Approve Merger Agreement with Fresenius Kabi

GlobeNewswire 6/9/2017 KISSEI TO MARKET AVACOPAN IN JAPAN FOR VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA

GlobeNewswire 4/7/2017 Akorn Confirms Discussions with Fresenius Kabi

GlobeNewswire 1/27/2011 Swedish Orphan Biovitrum agrees with Fresenius Biotech to distribute Removab®